Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Leiomyoma × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Pancreatic Neoplasms 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Leukemia 4 Recurrence 3 Neoplasms, Plasma Cell 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Radiodermatitis 2 Neoplasms by Site 2 Myelodysplastic Syndromes 2 Melanoma 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Transitional Cell 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

telapristone acetate 11 estradiol, norethindrone drug combination 6 elagolix 6 Estradiol 5 vilaprisan 4 Norethindrone Acetate 4 ulipristal acetate 3 relugolix 3 Uterine Myomectomy 2 Sugars 2 Letrozole 2 ulipristal 1 epigallocatechin gallate 1 Vitamin B 6 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Therapeutics 1 Standard of Care 1 Sodium Chloride 1 Rocuronium 1 Pregabalin 1 Morphine 1 Misoprostol 1 Mifepristone 1 Lidocaine 1 Leuprolide 1 Ibuprofen 1 Dexamethasone 1 Cryosurgery 1 Clomiphene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated

1,272 enrolled 16 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡